دورية أكاديمية

Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity.

التفاصيل البيبلوغرافية
العنوان: Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity.
المؤلفون: Del Rosal, Teresa, Quintana-Ortega, Cristian, Deyá-Martinez, Angela, Soler-Palacín, Pere, Goycochea-Valdivia, Walter Alfredo, Salmón, Nerea, Pérez-Martínez, Antonio, Alsina, Laia, Martín-Nalda, Andrea, Alonso, Laura, Neth, Olaf, Bravo-Gallego, Luz Yadira, Gonzalez-Granado, Luis Ignacio, Mendez-Echevarria, Ana
سنة النشر: 2022
المجموعة: Sistema Sanitario Público de Andalucía (SSPA): Repositorio
مصطلحات موضوعية: Cytomegalovirus, Genetic therapy, Hematopoietic stem cell transplantation, Inborn errors of immunity, Mortality, Child, Cytomegalovirus Infections, Humans, Retrospective Studies, Transplantation, Homologous
الوصف: The presence of active viral infections has an impact on the prognosis of patients undergoing hematopoietic stem cell transplantation (HSCT). Nevertheless, the number of reports of cytomegalovirus infection in patients with inborn errors of immunity (IEI) who undergo HSCT is relatively low. To analyze the effect of cytomegalovirus infection acquired prior to curative treatment on patient survival in 123 children with IEI. An observational and retrospective study was performed with patients younger than 18 years diagnosed with IEI who were candidates for HSCT, gene therapy, or thymus transplantation at five hospitals in Spain between 2008 and 2019. We included 123 children, 25 infected by cytomegalovirus prior to undergoing curative treatment (20.3%). At IEI diagnosis, 24 of the patients were already infected, 21 of whom had symptomatic cytomegalovirus disease (87%), while the other three patients developed disease before undergoing curative treatment. The patients with cytomegalovirus infection had higher mortality than those without (p = 0.006). Fourteen patients developed refractory cytomegalovirus infection (56%), all of whom died, while no patients with non-refractory infection died (p = 0.001) All deaths that occurred before curative treatment and three of the five after the treatment were attributed to cytomegalovirus. Patients with refractory cytomegalovirus disease had the highest pre-HSCT mortality rate (64.3%), compared with the non-infected children and those with non-refractory cytomegalovirus disease (10.1%) (p Prevention and prompt control of cytomegalovirus infection, together with early HSCT/gene therapy, are crucial for improving the prognosis in children with IEI. • Cytomegalovirus is the most frequent viral infection in children with inborn errors of immunity who are candidates to hematopoietic stem cell transplantation (HSCT). • Active viral infections at the time of HSCT lead to worse prognosis. • In children with inborn errors of immunity and indication of HSCT, refractory cytomegalovirus ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 36102997
1432-1076
العلاقة: http://hdl.handle.net/10668/20175Test; PMC9470503; https://link.springer.com/content/pdf/10.1007/s00431-022-04614-5.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470503/pdfTest
DOI: 10.1007/s00431-022-04614-5
DOI: 10.1007/s00431-022-04614-5.pdf
الإتاحة: https://doi.org/10.1007/s00431-022-04614-5Test
http://hdl.handle.net/10668/20175Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470503/pdfTest
حقوق: open access
رقم الانضمام: edsbas.B526AC9D
قاعدة البيانات: BASE
الوصف
تدمد:36102997
14321076
DOI:10.1007/s00431-022-04614-5